ACRS Past Earnings image   This ACRS past earnings page last updated 5/9/2024
ACRS Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/7/2024-0.240
Q4 20232/27/2024-0.300
Q3 202311/6/2023-0.410
Q2 20238/7/2023-0.420
Q1 20235/8/2023-0.420
Q4 20222/23/2023-0.410
Q3 202211/8/2022-0.300
Q2 20228/3/2022-0.310
Q1 20225/10/2022-0.310
Q4 20212/24/2022-0.370
Q3 202111/2/2021-0.350
Q2 20218/5/2021-0.340
Q1 20215/7/2021-0.570
Q4 20202/25/2021-0.300
Q3 202011/4/2020-0.250
Q2 20208/7/2020-0.280
Q1 20205/7/2020-0.370
Q4 20192/25/2020-0.450
Q3 201911/7/2019-0.560
Q2 20198/8/2019-0.760
Q1 20195/8/2019-0.910
Q4 20183/18/2019-0.99
Q3 201811/6/2018-1.06
Q2 20188/3/2018-1.01
Q1 20185/8/2018-0.98
Q4 20173/12/2018-0.8
Q3 201711/7/2017-0.63
Q2 20178/8/2017-0.56
Q1 20175/9/2017-0.48
Q4 20163/15/2017-0.49
Q3 201611/3/2016-0.5
Q2 20168/11/2016-0.62
Q1 20165/11/2016-0.65
Q4 20153/23/2016-0.28
Q3 201511/18/2015-5.11
ACRS Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/7/20240.00B
Q4 20232/27/20240.02B
Q3 202311/6/20230.01B
Q2 20238/7/20230.00B
Q1 20235/8/20230.00B
Q4 20222/23/20230.01B
Q3 202211/8/20220.02B
Q2 20228/3/20220.00B
Q1 20225/10/20220.00B
Q4 20212/24/20220.00B
Q3 202111/2/20210.00B
Q2 20218/5/20210.00B
Q1 20215/7/20210.00B
Q4 20202/25/20210.00B
Q3 202011/4/20200.00B
Q2 20208/7/20200.00B
Q1 20205/7/20200.00B
Q4 20192/25/20200.00B
Q3 201911/7/20190.00B
Q2 20198/8/20190.01B
Q1 20195/8/20190.01B
Q4 20183/18/20193.67M
Q3 201811/6/20181.63M
Q2 20188/3/20183.68M
Q1 20185/8/20181.12M
Q4 20173/12/2018999000
Q3 201711/7/2017684000
Q2 20178/8/2017NA
Q1 20175/9/2017NA
Q4 20163/15/2017NA
Q3 201611/3/2016NA
Q2 20168/11/2016NA
Q1 20165/11/2016NA
Q4 20153/23/2016NA
Q3 201511/18/2015NA
Quotes delayed 20 minutes

Email EnvelopeFree ACRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aclaris Therapeutics (ACRS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ACRV Past Earnings
ACRX Past Earnings
ACXP Past Earnings
ADGI Past Earnings
ADIL Past Earnings
ADMA Past Earnings
ADMP Past Earnings
ADMS Past Earnings
ADPT Past Earnings
ADTX Past Earnings

ACRS Past Earnings Q&A

What was the best and worst ACRS past earnings results?
For Aclaris Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ACRS past earnings result in our data set was -0.240/share posted in Q1 2024, while the lowest was in Q3 2015 when ACRS posted -5.11/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when ACRS reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q2 2017 at NA of revenue.

  Suggested answer: There are 35 ACRS past earnings results in our data set.

On this page we presented the ACRS past earnings date information for Aclaris Therapeutics. Reviewing that ACRS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2024, when ACRS posted gaap of -0.240/share. Meanwhile the lowest ACRS past earnings result was in Q3 2015, when ACRS posted gaap of -5.11/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when ACRS reported 0.02B in revenue, while the smallest revenue quarter was Q2 2017 when ACRS reported NA in revenue.

Any self directed investor doing their due diligence on ACRS or any other given stock can benefit from researching all of the Aclaris Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Aclaris Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACRS. Thanks for visiting, and the next time you need to research ACRS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding AEAE, INDP shares outstanding history, DCI Dividend History.


ACRS Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.